首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Identification and characterization of RNA aptamers: A long aptamer blocks the AMPA receptor and a short aptamer blocks both AMPA and kainate receptors
【2h】

Identification and characterization of RNA aptamers: A long aptamer blocks the AMPA receptor and a short aptamer blocks both AMPA and kainate receptors

机译:RNA适体的鉴定和表征:长适体会阻断AMPA受体而短适体会阻断AMPA和红藻氨酸受体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AMPA and kainate receptors, along with NMDA receptors, represent different subtypes of glutamate ion channels. AMPA and kainate receptors share a high degree of sequence and structural similarities, and excessive activity of these receptors has been implicated in neurological diseases such as epilepsy. Therefore, blocking detrimental activity of both receptor types could be therapeutically beneficial. Here, we report the use of an in vitro evolution approach involving systematic evolution of ligands by exponential enrichment with a single AMPA receptor target (i.e. GluA1/2R) to isolate RNA aptamers that can potentially inhibit both AMPA and kainate receptors. A full-length or 101-nucleotide (nt) aptamer selectively inhibited GluA1/2R with a KI of ∼5 μm, along with GluA1 and GluA2 AMPA receptor subunits. Of note, its shorter version (55 nt) inhibited both AMPA and kainate receptors. In particular, this shorter aptamer blocked equally potently the activity of both the GluK1 and GluK2 kainate receptors. Using homologous binding and whole-cell recording assays, we found that an RNA aptamer most likely binds to the receptor's regulatory site and inhibits it noncompetitively. Our results suggest the potential of using a single receptor target to develop RNA aptamers with dual activity for effectively blocking both AMPA and kainate receptors.
机译:AMPA和海藻酸酯受体以及NMDA受体代表了谷氨酸离子通道的不同亚型。 AMPA和海藻酸盐受体具有高度的序列和结构相似性,这些受体的过度活性与神经系统疾病如癫痫病有关。因此,阻断两种受体类型的有害活性可能在治疗上是有益的。在这里,我们报告了一种体外进化方法的使用,该方法涉及通过单个AMPA受体靶标(即GluA1 / 2R)的指数富集进行配体的系统进化,以分离可能潜在抑制AMPA和红藻氨酸受体的RNA适体。全长或101个核苷酸(nt)的适体选择性抑制KI约为5μm的GluA1 / 2R,以及GluA1和GluA2 AMPA受体亚基。值得注意的是,其较短的版本(55 nt)可抑制AMPA和红藻氨酸受体。特别是,这种较短的适体同样有效地阻断了GluK1和GluK2海藻酸酯受体的活性。使用同源结合和全细胞记录分析,我们发现RNA适体最有可能与受体的调节位点结合并非竞争性地抑制它。我们的结果表明使用单个受体靶标开发具有双重活性的RNA适体的潜力,可以有效地阻断AMPA和红藻氨酸受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号